$CLRB
Cellectar Biosciences, Inc.

2012 Q2 Form 10-Q Financial Statement

#000114420412026326 Filed on May 04, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q4
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $900.0K $1.000M $860.0K
YoY Change 13.92% 669.23% 514.29%
% of Gross Profit
Research & Development $1.315M $1.328M $1.160M
YoY Change 35.53% 181.78% 213.51%
% of Gross Profit
Depreciation & Amortization $130.0K $139.8K $140.0K
YoY Change -13.33% -3.05% 0.0%
% of Gross Profit
Operating Expenses $1.315M $1.328M $2.020M
YoY Change -24.88% 181.78% 296.08%
Operating Profit -$2.212M -$2.326M
YoY Change 172.5%
Interest Expense -$2.073K -$2.072K $50.00K
YoY Change -99.39% -98.67% -150.0%
% of Operating Profit
Other Income/Expense, Net -$19.31K -$30.92K $0.00
YoY Change -72.32% -100.0%
Pretax Income -$2.230M -$2.360M -$1.970M
YoY Change -14.23% 143.3% 328.26%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.231M -$2.357M -$1.970M
YoY Change -14.2% 144.17% 328.26%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$111.5M -$118.0M -$98.50M
COMMON SHARES
Basic Shares Outstanding 37.57M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.150M $3.790M $5.510M
YoY Change 116.01% 267.96% 722.39%
Cash & Equivalents $7.146M $3.788M $5.506M
Short-Term Investments
Other Short-Term Assets $200.0K $240.0K $310.0K
YoY Change 25.0% 300.0% -49.18%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.340M $4.026M $5.816M
YoY Change 110.92% 269.35% 354.37%
LONG-TERM ASSETS
Property, Plant & Equipment $2.810M $2.920M $3.045M
YoY Change -13.54% 29099.43% -13.26%
Goodwill $1.675M $1.675M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $30.00K $27.22K $27.22K
YoY Change 0.0% 172.22%
Total Long-Term Assets $4.510M $4.623M $4.747M
YoY Change -8.89% 23013.14% 34.87%
TOTAL ASSETS
Total Short-Term Assets $7.340M $4.026M $5.816M
Total Long-Term Assets $4.510M $4.623M $4.747M
Total Assets $11.85M $8.649M $10.56M
YoY Change 40.57% 679.14% 120.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $610.0K $470.0K $480.0K
YoY Change 64.86% 88.0% 23.08%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $640.0K $506.3K $503.6K
YoY Change 42.22% 12.51% -44.05%
LONG-TERM LIABILITIES
Long-Term Debt $450.0K $450.0K $450.0K
YoY Change -2.17% -87.67%
Other Long-Term Liabilities $130.0K $130.0K $120.0K
YoY Change 8.33% -63.89% 0.0%
Total Long-Term Liabilities $580.0K $580.9K $578.5K
YoY Change 0.0% 61.35% -84.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $640.0K $506.3K $503.6K
Total Long-Term Liabilities $580.0K $580.9K $578.5K
Total Liabilities $1.220M $1.087M $1.082M
YoY Change 19.61% 35.9% -76.83%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $369.00 $369.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.63M $7.561M $9.481M
YoY Change
Total Liabilities & Shareholders Equity $11.85M $8.649M $10.56M
YoY Change 40.57% 679.14% 120.07%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q4
OPERATING ACTIVITIES
Net Income -$2.231M -$2.357M -$1.970M
YoY Change -14.2% 144.17% 328.26%
Depreciation, Depletion And Amortization $130.0K $139.8K $140.0K
YoY Change -13.33% -3.05% 0.0%
Cash From Operating Activities -$1.500M -$1.703M -$1.540M
YoY Change -41.86% 424.61% 1300.0%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $15.15K -$10.00K
YoY Change -50.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00K -$15.15K $0.00
YoY Change -100.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.870M -544.0 5.460M
YoY Change 15.68% -98.92% 1265.0%
NET CHANGE
Cash From Operating Activities -1.500M -1.703M -1.540M
Cash From Investing Activities -10.00K -15.15K 0.000
Cash From Financing Activities 4.870M -544.0 5.460M
Net Change In Cash 3.360M -1.718M 3.920M
YoY Change 11.63% 358.15% 1251.72%
FREE CASH FLOW
Cash From Operating Activities -$1.500M -$1.703M -$1.540M
Capital Expenditures -$10.00K $15.15K -$10.00K
Free Cash Flow -$1.490M -$1.718M -$1.530M
YoY Change -41.8% 429.27% 1290.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
471629
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8648503
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37570245 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298667
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27222
CY2012Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3507
CY2012Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2275
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
506301
CY2012Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
32397
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
183300
CY2012Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
55000
CY2012Q1 us-gaap Assets
Assets
8648503
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
369
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
580875
CY2012Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
127368
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36962264 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000 shares
CY2012Q1 us-gaap Assets Current
AssetsCurrent
4025876
CY2012Q1 us-gaap Goodwill
Goodwill
1675462
CY2012Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
33837329
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3787576
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41398287
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
7561327
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36962264 shares
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2919943
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q1 us-gaap Liabilities
Liabilities
1087176
CY2012Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
450000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
673739
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27222
CY2011Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
4091
CY2011Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2235
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
254967
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
55000
CY2011Q4 us-gaap Assets
Assets
10563176
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
369
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Share Based Compensation
ShareBasedCompensation
3272226
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
91500
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
503581
CY2011Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
23305
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
578472
CY2011Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
124381
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36907824 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000 shares
CY2011Q4 us-gaap Assets Current
AssetsCurrent
5815927
CY2011Q4 us-gaap Goodwill
Goodwill
1675462
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
31480426
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5505960
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40961180
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
478041
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10563176
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
9481123
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36907824 shares
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3044565
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2011Q4 us-gaap Liabilities
Liabilities
1082053
CY2011Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
450000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
31667
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
28500
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
905649
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4663763
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1161
us-gaap Costs And Expenses
CostsAndExpenses
33592768
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
250000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
5192
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26835397
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
89520
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
145
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
439615
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
127368
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-36477
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
55000
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
-471765
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1227944
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
19671
us-gaap Net Income Loss
NetIncomeLoss
-33837329
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-244561
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22133353
us-gaap Increase Decrease In Fair Value Of Unhedged Derivative Instruments
IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments
-41004
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2555809
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-449197
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5501741
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19671
us-gaap Operating Income Loss
OperatingIncomeLoss
-33592768
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5500730
us-gaap Revenue From Grants
RevenueFromGrants
244479
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31874254
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2720985
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3787576
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
167130
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
78407
us-gaap Interest Paid
InterestPaid
208689
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
463722
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
5500730
us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
799133
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10660282
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35286736
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1677945
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.87
nvlt Issuance Of Common Stock In Exchange For Convertible Notes
IssuanceOfCommonStockInExchangeForConvertibleNotes
3184707
nvlt Supplemental Goodwill
SupplementalGoodwill
1675462
nvlt Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
68093
nvlt Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
11775244 shares
CY2011Q1 us-gaap Costs And Expenses
CostsAndExpenses
853564
CY2011Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
508
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-324566
CY2011Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
4323
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
58462
CY2011Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
293383
CY2011Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
49998
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-965252
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-111688
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
471404
CY2011Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
144174
CY2011Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-156167
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-853564
CY2011Q1 us-gaap Revenue From Grants
RevenueFromGrants
44479
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-375072
CY2011Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5458
CY2011Q1 us-gaap Interest Paid
InterestPaid
11563
CY2011Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
145802
CY2011Q1 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
250434
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
131726
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50506
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2011Q1 nvlt Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
12820102 shares
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Trading Symbol
TradingSymbol
NVLT
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
NOVELOS THERAPEUTICS, INC.
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001279704
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15149
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
2325985
CY2012Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
544
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1702691
CY2012Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
2987
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
417353
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6412
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-2356903
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30918
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1328314
CY2012Q1 us-gaap Increase Decrease In Fair Value Of Unhedged Derivative Instruments
IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments
-28846
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
139771
CY2012Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2072
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15149
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2325985
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1718384
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-71667
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
997671
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-544
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2012Q1 nvlt Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
19754
CY2012Q1 nvlt Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
36910217 shares

Files In Submission

Name View Source Status
0001144204-12-026326-index-headers.html Edgar Link pending
0001144204-12-026326-index.html Edgar Link pending
0001144204-12-026326.txt Edgar Link pending
0001144204-12-026326-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
nvlt-20120331.xml Edgar Link completed
nvlt-20120331.xsd Edgar Link pending
nvlt-20120331_cal.xml Edgar Link unprocessable
nvlt-20120331_def.xml Edgar Link unprocessable
nvlt-20120331_lab.xml Edgar Link unprocessable
nvlt-20120331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v310237_10q.htm Edgar Link pending
v310237_ex31-1.htm Edgar Link pending
v310237_ex31-2.htm Edgar Link pending
v310237_ex32-1.htm Edgar Link pending